Agios Pharma (AGIO) Misses Q4 EPS by 18c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($0.76), $0.18 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $14.64 million versus the consensus estimate of $10.94 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Agios Pharma (AGIO) PT Raised to $32 at RBC Capital
• Piper Sandler Reiterates Overweight Rating on Reddit (RDDT)